![Chris Cline](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Cline
Directeur Financier/CFO chez TRAVERE THERAPEUTICS, INC.
Fortune : 582 379 $ au 30/06/2024
Profil
Chris Cline is currently a Member at the National Investor Relations Institute.
He is also currently serving as the Chief Financial Officer at Travere Therapeutics, Inc. since 2014.
Mr. Cline completed his undergraduate degree at Williams College of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
11/04/2024 | 70 849 ( 0,09% ) | 582 379 $ | 30/06/2024 |
Postes actifs de Chris Cline
Sociétés | Poste | Début |
---|---|---|
TRAVERE THERAPEUTICS, INC. | Directeur Financier/CFO | 31/08/2022 |
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Anciens postes connus de Chris Cline
Sociétés | Poste | Fin |
---|---|---|
Elan Corp. Plc
![]() Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01/02/2014 |
Phase Forward, Inc.
![]() Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formation de Chris Cline
Williams College of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Elan Corp. Plc
![]() Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Phase Forward, Inc.
![]() Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Technology Services |